Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response

References

• Agarwal V, McHutchison J, Hoofnagle J, for the Drug-Induced Liver Injury Network (DILIN). 2010. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol. 8:463–470.
   PubMed Web of Science ®Google Scholar
• Bonkovsky H, Jones D, Russo M. 2012. Chapter 25: Drug-induced liver injury. In: Boyer T, Manns M, Sanyal A, editors. Zakim and Boyer’s hepatology: A textbook of liver disease. 6th ed. Philadelphia (PA): Saunders-Elsevier; p. 417–461.
   Google Scholar
• Castell J, Castell M. 2006. Allergic hepatitis induced by drugs. Curr Opin Allergy Clin Immunol. 6:258–265.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Bonkovsky H, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy K, Watkins P, Navarro V, Barnhart H, et al. 2015. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology. 148:1340–1352.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Fontana R, Bonkovsky H, Watkins P, Davern T, Serrano J, Yang H, Rochon J, Drug Induced Liver Injury. 2008. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 135:1924–1934.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Hayashi P, Bonkovsky H, Navarro V, Lee W, Fontana R, on behalf of the Practice Parameters Committee of the American College of Gastroenterology. 2014. The diagnosis and management of idiosyncratic drug-induced liver injury: Practice guideline by the American College of Gastroenterology. Am J Gastroenterol. 109:950–966.
   PubMed Web of Science ®Google Scholar
• de Lemos A, Ghabril M, Rockey D, Gu J, Barnhart H, Fontana R, Kleiner D, Bonkovsky H, for the US DILIN Investigators. 2016. Amoxicillin-clavulanate-induced liver injury. Digest Dis Sci. 61:2406–2416.
   PubMed Web of Science ®Google Scholar
• Fontana R, Hayashi P, Barnhart H, Kleiner D, Reddy K, Chalasani N, Lee W, Stolz A, Serrano J, Watkins P, for the DILIN investigators. 2015. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. Am J Gastroenterol. 110:1450–1459.
   PubMed Web of Science ®Google Scholar
• Fontana R, Seeff L, Andrade R, Bjornsson E, Day C, Serrano J, Hoofnagle J. 2010. Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop. Hepatology. 52:730–742.
   PubMedGoogle Scholar
• Fontana R, Watkins P, Bonkovsky H, Chalasani N, Davern T, Serrano J, Rochon J, Group D. 2009. Drug-Induced Liver Injury Network (DILIN) prospective study: Rationale, design and conduct. Drug Saf. 32:55–68.
   PubMed Web of Science ®Google Scholar
• Foureau D, Walling T, Maddukuri V, Anderson W, Culbreath K, Kleiner D, Ahrens W, Jacobs C, Watkins P, Fontana R, et al. 2015. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis. Clin Exp Immunol. 180:40–51.
   PubMed Web of Science ®Google Scholar
• Ju C. 2005. Immunological mechanisms of drug-induced liver injury. Curr Opin Drug Discov Dev. 8:38–43.
   PubMed Web of Science ®Google Scholar
• Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. 2007. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: Dependence on its timing and the type of drug eruption. Allergy. 62:1439–1444.
   PubMed Web of Science ®Google Scholar
• Kim S, Saide K, Farrell J, Faulkner L, Tailor A, Ogese M, Daly A, Pirmohamed M, Park B, Naisbitt D. 2015. Characterization of amoxicillin- and clavulanic acid-specific T-cells in patients with amoxicillin-clavulanate-induced liver injury. Hepatology. 62:887–899.
   PubMed Web of Science ®Google Scholar
• Kleiner D, Chalasani N, Lee W, Fontana R, Bonkovsky H, Watkins P, Hayashi P, Davern T, Navarro V, Reddy R, et al. 2014. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Hepatology. 59:661–670.
   PubMed Web of Science ®Google Scholar
• Lochmatter P, Beeler A, Kawabata T, Gerber B, Pichler W. 2009. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-γ in patients with delayed-type drug hypersensitivity. Allergy. 64:1269–1278.
   PubMed Web of Science ®Google Scholar
• Lochmatter P, Zawodniak A, Pichler W. 2009. In vitro tests in drug hypersensitivity diagnosis. Immunol Allergy Clin North Am. 29:537–554.
   PubMed Web of Science ®Google Scholar
• Lucena M, Molokhia M, Shen Y, Urban T, Aithal G, Andrade R, Day C, Ruiz-Caballo F, Donaldson P, Stephens C, et al. 2011. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 141:338–347.
   PubMed Web of Science ®Google Scholar
• Maria V, Victorino R. 1997. Diagnostic value of specific T-cell reactivity to drugs in 95 cases of drug induced liver injury. Gut. 41:534–540.
   PubMed Web of Science ®Google Scholar
• Metushi I, Cai P, Zhu X, Nakagawa T, Uetrecht J. 2011. A fresh look at the mechanism of isoniazid-induced hepatotoxicity. Clin Pharmacol Ther. 89:911–914.
   PubMed Web of Science ®Google Scholar
• Mizoguchi Y, Yamada T, Monna T, Yamamoto S, Morisawa S. 1975. Detection of hypersensitivity to drugs by lymphocyte cultures in drug-induced allergic hepatitis. Gastroenterol Japan. 10:300–306.
   PubMedGoogle Scholar
• Murata H, Shimizu Y, Okada K, Higuchi K, Watanabe A. 2003. Detection and analysis of intracytoplasmic cytokines in peripheral blood mononuclear cells in patients with drug-induced liver injury. J Hepatol. 38:573–582.
   PubMed Web of Science ®Google Scholar
• Naisbitt D, Nattrass R, Ogese M. 2014. In vitro diagnosis of delayed-type drug hypersensitivity: Mechanistic aspects and unmet needs. Immunol Allergy Clin North Am. 34:691–705.
   PubMed Web of Science ®Google Scholar
• Navarro V, Barnhart H, Bonkovsky H, Davern T, Fontana R, Grant L, Hayashi P, Reddy K, Seeff L, Serrano J, et al. 2014. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 60:1399–1408.
   PubMed Web of Science ®Google Scholar
• Pichler W, Tilch J. 2004. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 59:809–820.
   PubMed Web of Science ®Google Scholar
• Porebski G, Pecaric-Petkovic T, Groux-Keller M, Bosak M, Kawabata T, Pichler W. 2013. In vitro drug causality assessment in Stevens-Johnson syndrome – alternatives for lymphocyte transformation test. Clin Exp Immunol. 43:1027–1037.
   Google Scholar
• Rochon J, Protiva P, Seeff L, Fontana R, Liangpunsakul S, Hayashi P, Davern T, McHutchison J, the Drug-Induced Liver Injury Network (DILIN). 2008. The reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology. 48:1175–1183.
   PubMed Web of Science ®Google Scholar
• Rockey D, Seeff L, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana R, Hayashi P, Network USD-ILI. 2010. Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method. Hepatology. 51:2117–2126.
   PubMed Web of Science ®Google Scholar
• Seeff L, Bonkovsky H, Navarro V, Wang G. 2015. Herbal products and the liver: A review of adverse effects and mechanisms. Gastroenterology. 148:517–532.
   PubMed Web of Science ®Google Scholar
• Steuerwald N, Foureau D, Norton H, Zhou J, Parsons J, Chalasani N, Fontana R, Watkins P, Lee W, Reddy R, et al. 2013. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One. 8:e8194.
   Web of Science ®Google Scholar
• Tujios S, Fontana R. 2011. Mechanisms of drug-induced liver injury: From bedside to bench. Nat Rev Gastroenterol Hepatol. 8:202–211.
   PubMed Web of Science ®Google Scholar
• Warrington R, McPhilips-Feener S, Rutherford W. 1982. The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis. Clin Allergy. 12:217–222.
   PubMedGoogle Scholar
• Warrington R, Tse K, Gorski B, Schwenk R, Sehon A. 1978. Evaluation of isoniazid-associated hepatitis by immunological tests. Clin Exp Immunol. 32:97–104.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Shibuya A. 2004. Validity study of a new diagnostic scale for drug-induced liver injury in Japan – comparison with two previous scales. Hepatol Res. 30:148–154.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Kurita C, Yamazaki F, Nakano S, Nagai H. 1994. Lymphocyte stimulation test with tetrazolium-based colorimetric assay for diagnosis of drug-induced allergic hepatitis. Biol Pharm Bull. 17:921–926.
   PubMed Web of Science ®Google Scholar
• Zawodniak A, Lochmatter P, Yerly D, Kawabata T, Lerch M, Yawalkar N, Pichler W. 2010. In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy. 65:376–384.
   PubMed Web of Science ®Google Scholar